Medical Spa MD: End of the Road for Evolence

I must say I am a little disappointed in my former company of employment, but on November 3rd Johnson & Johnson, Inc. announced that they will no longer be manufacturing or marketing Evolencedermal filler in the United States just a year after they received their FDA approval.

Ortho Dermatologics porcine derived collagen filler was gaining in popularity with many clinicians across the U.S. praising the product for its ease of injection and smoothness in appearance and feel. Although few in number, the main complaint of the product from a consumer standpoint was that they wished it lasted longer. However, many went on to say the look and feel of the results far outweighed its lasting effects.

Johnson & Johnson, Inc. has not stated a definite reason for why the product is being pulled from the U.S. market. A statement on their website reads:

"On November 3, 2009, we announced our intention to discontinue the manufacture and marketing of EVOLENCE^®products. Patients and medical professionals who may currently be using EVOLENCE^® products can be assured that they remain effective for the approved indications with a favorable safety profile. EVOLENCE^® products will continue to be supported for medical inquiries and adverse event reporting, in accordance with regulatory requirements."

Author: Paula D. Young RN runs internal operations and training at Young Medical Spa and is the author of the Medical Spa Aesthetics Course, Study Guide, and Advanced IPL & Laser Training course for medical estheticians and laser technicians.

Submit a guest post and be heard.